Fei Ye
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 58
- Cancer Immunotherapy and Biomarkers 22
- CAR-T cell therapy research 8
-
- Cancer-related molecular mechanisms research 20
- MicroRNA in disease regulation 10
- Cancer Genomics and Diagnostics 8
- Co-authors
- Yu Shyr (29 shared papers)Douglas Buckner Johnson (25 shared papers)Yan Ping Guo (18 shared papers)Shilin Zhao (11 shared papers)Quanhu Sheng (13 shared papers)David C. Samuels (7 shared papers)Daniel Y. Wang (5 shared papers)Run Fan (16 shared papers)
- Journals
- JAMA Oncology (7 papers)Cancer Research (7 papers)International Journal of Cancer (5 papers)Cancer Immunology Research (5 papers)The Oncologist (5 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Fei Ye
223 papers receiving 11.4k citations
Fei Ye's Hit Papers
Peers
Comparison fields: 5 of 164
- Oncology 4.9k
- Cancer Research 1.4k
- Molecular Biology 4.1k
- Immunology 1.2k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Fei Ye
This map shows the geographic impact of Fei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ye more than expected).
Fields of papers citing papers by Fei Ye
This network shows the impact of papers produced by Fei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ye. The network helps show where Fei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 231 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors Hit paper breakdown → | 2018 | 2160 |
| 2 | Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib Hit paper breakdown → | 2012 | 1823 |
| 3 | Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders Hit paper breakdown → | 2015 | 555 |
| 4 | 2015 | 272 | |
| 5 | 2019 | 234 | |
| 6 | 2021 | 185 | |
| 7 | 2017 | 181 | |
| 8 | 2013 | 160 | |
| 9 | 2010 | 150 | |
| 10 | 2011 | 137 | |
| 11 | 2021 | 130 | |
| 12 | 2021 | 125 | |
| 13 | 2017 | 116 | |
| 14 | 2011 | 104 | |
| 15 | 2011 | 101 | |
| 16 | 2013 | 101 | |
| 17 | 2007 | 100 | |
| 18 | 2016 | 94 | |
| 19 | 2019 | 93 | |
| 20 | 2010 | 90 |
About Fei Ye
Fei Ye is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 231 papers that have together received 11.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (11 papers), MicroRNA in disease regulation (10 papers), CAR-T cell therapy research (8 papers), Cancer Genomics and Diagnostics (8 papers), Circular RNAs in diseases (8 papers) and Melanoma and MAPK Pathways (8 papers). The work is most often cited by research in Oncology (4.9k citations), Cancer Research (1.4k citations), Molecular Biology (4.1k citations), Immunology (1.2k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Fei Ye has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Yu Shyr, Douglas Buckner Johnson, Yan Ping Guo, Shilin Zhao, Quanhu Sheng, David C. Samuels, Daniel Y. Wang, Run Fan, Elizabeth J. Davis and Jiang Li. Their work appears in journals such as JAMA Oncology, Cancer Research, International Journal of Cancer, Cancer Immunology Research and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.